论文信息 - Switching from double-blind entacapone or placebo to open-label opicapone: change in OFF-/ON-time from patients who ended the 1-year BIPARK-I extension on opicapone 50 mg - 字舞流文

Switching from double-blind entacapone or placebo to open-label opicapone: change in OFF-/ON-time from patients who ended the 1-year BIPARK-I extension on opicapone 50 mg

W. Poewe | O. Rascol | A. Lees | J. Ferreira | P. Soares-da-Silva | F. Rocha | D. Magalhães | F. Ikedo

[1] W. Poewe,et al. Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial , 2017, JAMA neurology.

[2] Werner Poewe,et al. Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial , 2016, The Lancet Neurology.